Astronics, nLIGHT, Kadant, Montrose, and Novanta Shares Are Falling, What You Need To KnowA number of stocks fell in the afternoon session after an unexpectedly sharp rise in wholesale inflation fueled concerns about rising costs and their impact on corporate profits. The primary catalyst was the July 2025 Producer Price Index (PPI), a measure of inflation at the wholesale level, which jumped 0.9% against forecasts of a 0.2% rise. This represents the most significant monthly increase in over three years, pointing to mounting cost pressures for manufacturers, with tariffs cited as a key factor. This data complicates the Federal Reserve's upcoming interest rate decisions, as persistent inflation may prevent rate cuts, creating a headwind for cyclical sectors like Industrials.
NOVT Q2 Deep Dive: Medical Device Growth Offset by Guidance Caution and Trade UncertaintyMedicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next quarter’s revenue guidance of $245.5 million was less impressive, coming in 3.8% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.6% above analysts’ consensus estimates.
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY.
Novanta’s (NASDAQ:NOVT) Q2: Beats On Revenue But Quarterly Revenue Guidance Misses ExpectationsMedicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) announced better-than-expected revenue in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next quarter’s revenue guidance of $245.5 million was less impressive, coming in 3.6% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.6% above analysts’ consensus estimates.
Novanta Announces Financial Results for the Second Quarter 2025
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025.
Novanta (NOVT) Q2 Earnings Report Preview: What To Look ForMedicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) will be reporting earnings this Tuesday before market open. Here’s what to expect.
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025.
3 Cash-Producing Stocks Facing HeadwindsA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Profitable Stocks Walking a Fine LineNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York.
3 Industrials Stocks Facing HeadwindsIndustrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow.
Due to this bearish outlook, the industry has tumbled by 6.6% over the past six months. This drop was disappointing since the S&P 500 held its ground.
Q1 Earnings Outperformers: Novanta (NASDAQ:NOVT) And The Rest Of The Electronic Components StocksEarnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Novanta (
NASDAQ:NOVT) and its peers.
NOVT Q1 Earnings Call: Resilient Performance Amid Trade Headwinds and Strategic AcquisitionMedicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY.
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, in Chicago, IL.
Novanta’s (NASDAQ:NOVT) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 12.3%Medicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.
Novanta Announces Financial Results for the First Quarter 2025
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025.
Novanta (NOVT) Q1 Earnings Report Preview: What To Look ForMedicine and manufacturing technology provider Novanta (
NASDAQ:NOVT) will be announcing earnings results tomorrow before the bell. Here’s what to expect.
3 Small-Cap Stocks with Questionable FundamentalsInvestors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Reflecting On Electronic Components Stocks’ Q4 Earnings: Novanta (NASDAQ:NOVT)Wrapping up Q4 earnings, we look at the numbers and key takeaways for the electronic components stocks, including Novanta (
NASDAQ:NOVT) and its peers.
Electronic Components Stocks Q4 Recap: Benchmarking Vishay Precision (NYSE:VPG)As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at electronic components stocks, starting with Vishay Precision (
NYSE:VPG).
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2025 results on Tuesday, May 6, 2025.
